Search

Your search keyword '"Tam, Roger"' showing total 29 results

Search Constraints

Start Over You searched for: Author "Tam, Roger" Remove constraint Author: "Tam, Roger" Language undetermined Remove constraint Language: undetermined
29 results on '"Tam, Roger"'

Search Results

1. MProtoNet: A Case-Based Interpretable Model for Brain Tumor Classification with 3D Multi-parametric Magnetic Resonance Imaging

2. sj-docx-1-msj-10.1177_13524585231164295 – Supplemental material for Employment status, productivity loss, and associated factors among people with multiple sclerosis

3. Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses

4. sj-docx-1-msj-10.1177_13524585231164295 – Supplemental material for Employment status, productivity loss, and associated factors among people with multiple sclerosis

5. SSiT: Saliency-guided Self-supervised Image Transformer for Diabetic Retinopathy Grading

6. sj-docx-1-msj-10.1177_13524585211069070 ��� Supplemental material for Productivity loss among people with early multiple sclerosis: A Canadian study

7. sj-docx-1-msj-10.1177_13524585211069070 ��� Supplemental material for Productivity loss among people with early multiple sclerosis: A Canadian study

8. sj-pdf-1-msj-10.1177_13524585211023345 – Supplemental material for Characterization of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging

9. sj-pdf-2-msj-10.1177_13524585211023345 – Supplemental material for Characterization of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging

10. sj-pdf-5-msj-10.1177_13524585211023345 – Supplemental material for Characterization of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging

11. sj-pdf-4-msj-10.1177_13524585211023345 – Supplemental material for Characterization of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging

12. sj-pdf-2-msj-10.1177_13524585211023345 – Supplemental material for Characterization of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging

13. sj-pdf-3-msj-10.1177_13524585211023345 – Supplemental material for Characterization of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging

14. sj-pdf-3-msj-10.1177_13524585211023345 – Supplemental material for Characterization of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging

15. sj-pdf-5-msj-10.1177_13524585211023345 – Supplemental material for Characterization of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging

16. sj-pdf-4-msj-10.1177_13524585211023345 – Supplemental material for Characterization of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging

17. Additional file 2 of Reshaping the path of vascular cognitive impairment with resistance training: a study protocol for a randomized controlled trial

18. Additional file 1 of The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design

19. Additional file 1 of Reshaping the path of vascular cognitive impairment with resistance training: a study protocol for a randomized controlled trial

20. Introduction to a novel T2 relaxation analysis method SAME-ECOS: Spectrum Analysis for Multiple Exponentials via Experimental Condition Oriented Simulation

21. Supplemental material for Advanced imaging findings in progressive solitary sclerosis: a single lesion or a global disease?

22. MSJ770085_supplementary_appendix – Supplemental material for A 24-month advanced magnetic resonance imaging study of multiple sclerosis patients treated with alemtuzumab

26. MSO879952 Supplemental Material2 - Supplemental material for Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a

27. MSO879952 Supplemental Material2 - Supplemental material for Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a

28. MSO879952 Supplemental Material1 - Supplemental material for Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a

29. MSO879952 Supplemental Material1 - Supplemental material for Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a

Catalog

Books, media, physical & digital resources